Engineered Lactobacillus rhamnosus GG expressing IgG-binding domains of protein G: Capture of hyperimmune bovine colostrum antibodies and protection against diarrhea in a mouse pup rotavirus infection model - PubMed (original) (raw)

Engineered Lactobacillus rhamnosus GG expressing IgG-binding domains of protein G: Capture of hyperimmune bovine colostrum antibodies and protection against diarrhea in a mouse pup rotavirus infection model

Gökçe Günaydın et al. Vaccine. 2014.

Abstract

Rotavirus-induced diarrhea causes more than 500,000 deaths annually in the world, and although vaccines are being made available, new effective treatment strategies should still be considered. Purified antibodies derived from hyperimmune bovine colostrum (HBC), from cows immunized with rotavirus, were previously used for treatment of rotavirus diarrhea in children. A combination of HBC antibodies and a probiotic strain of Lactobacillus (L. rhamnosus GG) was also found to be more effective than HBC alone in reducing diarrhea in a mouse model of rotavirus infection. In order to further improve this form of treatment, L. rhamnosus GG was engineered to display surface expressed IgG-binding domains of protein G (GB1, GB2, and GB3) which capture HBC-derived IgG antibodies (HBC-IgG) and thus target rotavirus. The expression of IgG-binding domains on the surface of the bacteria as well as their binding to HBC-IgG and to rotavirus (simian strain RRV) was demonstrated by Western blot, flow cytometry, and electron microscopy. The prophylactic effect of engineered L. rhamnosus GG and anti-rotaviral activity of HBC antibodies was evaluated in a mouse pup model of RRV infection. The combination therapy with engineered L. rhamnosus GG (PG3) and HBC was significantly more effective in reducing the prevalence, severity, and duration of diarrhea in comparison to HBC alone or a combination of wild-type L. rhamnosus GG and HBC. The new therapy reduces the effective dose of HBC between 10 to 100-fold and may thus decrease treatment costs. This antibody capturing platform, tested here for the first time in vivo, could potentially be used to target additional gastrointestinal pathogens.

Keywords: GB1-3; HBC; HBC-IgG; Hyperimmune bovine colostrum; IgG; IgG-binding domains GB1, GB2, and GB3 of protein G; Lactobacillus rhamnosus GG; Neonatal mouse model; Probiotic; Protein G; RRV; Rotavirus; hyperimmune bovine colostrum; hyperimmune bovine colostrum derived-IgG antibodies; immunoglobulin G; rhesus rotavirus.

PubMed Disclaimer

Cited by

An Exopolysaccharide-Deficient Mutant of Lactobacillus rhamnosus GG Efficiently Displays a Protective Llama Antibody Fragment against Rotavirus on Its Surface.
Álvarez B, Krogh-Andersen K, Tellgren-Roth C, Martínez N, Günaydın G, Lin Y, Martín MC, Álvarez MA, Hammarström L, Marcotte H. Álvarez B, et al. Appl Environ Microbiol. 2015 Sep 1;81(17):5784-93. doi: 10.1128/AEM.00945-15. Epub 2015 Jun 19. Appl Environ Microbiol. 2015. PMID: 26092449 Free PMC article.
Lacticaseibacillus rhamnosus: A Suitable Candidate for the Construction of Novel Bioengineered Probiotic Strains for Targeted Pathogen Control.
Mathipa-Mdakane MG, Thantsha MS. Mathipa-Mdakane MG, et al. Foods. 2022 Mar 8;11(6):785. doi: 10.3390/foods11060785. Foods. 2022. PMID: 35327208 Free PMC article. Review.
The protective role of prebiotics and probiotics on diarrhea and gut damage in the rotavirus-infected piglets.
Yang H, Fan X, Mao X, Yu B, He J, Yan H, Wang J. Yang H, et al. J Anim Sci Biotechnol. 2024 May 3;15(1):61. doi: 10.1186/s40104-024-01018-3. J Anim Sci Biotechnol. 2024. PMID: 38698473 Free PMC article. Review.
Co-expression of anti-rotavirus proteins (llama VHH antibody fragments) in Lactobacillus: development and functionality of vectors containing two expression cassettes in tandem.
Günaydın G, Alvarez B, Lin Y, Hammarström L, Marcotte H. Günaydın G, et al. PLoS One. 2014 Apr 29;9(4):e96409. doi: 10.1371/journal.pone.0096409. eCollection 2014. PLoS One. 2014. PMID: 24781086 Free PMC article.
Combined use of lactic-acid-producing bacteria as probiotics and rotavirus vaccine candidates expressing virus-specific proteins.
Afchangi A, Latifi T, Jalilvand S, Marashi SM, Shoja Z. Afchangi A, et al. Arch Virol. 2021 Apr;166(4):995-1006. doi: 10.1007/s00705-021-04964-9. Epub 2021 Feb 3. Arch Virol. 2021. PMID: 33533975 Review.

Engineered Lactobacillus rhamnosus GG expressing IgG-binding domains of protein G: Capture of hyperimmune bovine colostrum antibodies and protection against diarrhea in a mouse pup rotavirus infection model - PubMed (original) (raw)